BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12548563)

  • 1. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.
    Jeannin P; Magistrelli G; Herbault N; Goetsch L; Godefroy S; Charbonnier P; Gonzalez A; Delneste Y
    Eur J Immunol; 2003 Feb; 33(2):326-33. PubMed ID: 12548563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity.
    Steigerwald M; Moll H
    Infect Immun; 2005 Apr; 73(4):2564-7. PubMed ID: 15784607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.
    Sozzani S; Allavena P; D'Amico G; Luini W; Bianchi G; Kataura M; Imai T; Yoshie O; Bonecchi R; Mantovani A
    J Immunol; 1998 Aug; 161(3):1083-6. PubMed ID: 9686565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells.
    Weng Y; Sun J; Wu Q; Pan J
    J Neuroimmunol; 2007 Jan; 182(1-2):48-54. PubMed ID: 17081624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5.
    Varani S; Frascaroli G; Homman-Loudiyi M; Feld S; Landini MP; Söderberg-Nauclér C
    J Leukoc Biol; 2005 Feb; 77(2):219-28. PubMed ID: 15522919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.
    Yanagihara S; Komura E; Nagafune J; Watarai H; Yamaguchi Y
    J Immunol; 1998 Sep; 161(6):3096-102. PubMed ID: 9743376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells.
    Vecchi A; Massimiliano L; Ramponi S; Luini W; Bernasconi S; Bonecchi R; Allavena P; Parmentier M; Mantovani A; Sozzani S
    J Leukoc Biol; 1999 Sep; 66(3):489-94. PubMed ID: 10496320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression.
    Page G; Miossec P
    J Pathol; 2004 Sep; 204(1):28-38. PubMed ID: 15307135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines.
    Alder J; Hahn-Zoric M; Andersson BA; Karlsson-Parra A
    Vaccine; 2006 Nov; 24(49-50):7087-94. PubMed ID: 16889876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
    Zhu K; Shen Q; Ulrich M; Zheng M
    Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
    Kaufmann A; Salentin R; Gemsa D; Sprenger H
    J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
    Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
    Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.
    Kellermann SA; Hudak S; Oldham ER; Liu YJ; McEvoy LM
    J Immunol; 1999 Apr; 162(7):3859-64. PubMed ID: 10201903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
    Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.